Delivering nucleic acids using lipid nanoparticles (LNP) to target cells has tremendous potential to enable new cell and gene therapies. In this webinar, we'll share insights on an innovative genomic medicines toolkit, focusing on technologies that streamline the development of RNA-LNP medicines.
We're excited to introduce you to off-the-shelf reagents designed specifically for producing RNA-LNPs optimized for hematopoietic stem cells (HSC), alongside the NanoAssemblr™ manufacturing platform equipped with NxGen™ technology. This platform can enable rapid development and scale-up production of RNA-LNPs. Through this presentation, we will walk you through data for ex vivo hematopoietic stem cell therapies showcasing how LNPs serve as a vehicle for RNA delivery for the transient expression of therapeutic genes and gene-editing nucleases.
Join us in this webinar to learn more about: